Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer

Autor: S. Chraibi, R. Rosière, E. De Prez, P. Gérard, MH. Antoine, I. Langer, J. Nortier, M. Remmelink, K. Amighi, N. Wauthoz

Publikováno v: Biomedicine & Pharmacotherapy, Vol 139, Iss , Pp 111716- (2021)

Despite the advances in targeted therapies and immunotherapy for non-small cell lung cancer (NSCLC) patients, the intravenous administration of carboplatin (CARB) and paclitaxel (PTX) in well-spaced cycles is widely indicated for the treatment of NSC

Externí odkaz: https://doaj.org/article/15479d308f414f36ad8637ecaa8bbc9a

Pulmonary Congestion and Anemia in Hemodialysis: The Potential Link to Inflammation.

Autor: Kaysi S; Nephrology Department, Brugmann University Hospital, Université libre de Bruxelles, 4 place Van Gehuchten, 1020 Brussels, Belgium.; Laboratory of Experimental Nephrology, Faculty of Medicine, Université libre de Bruxelles, Erasme Campus, 808 route de Lennik, 1070 Brussels, Belgium., Pacha B; Nephrology Department, Brugmann University Hospital, Université libre de Bruxelles, 4 place Van Gehuchten, 1020 Brussels, Belgium., Antoine MH; Laboratory of Experimental Nephrology, Faculty of Medicine, Université libre de Bruxelles, Erasme Campus, 808 route de Lennik, 1070 Brussels, Belgium., De Prez E; Laboratory of Experimental Nephrology, Faculty of Medicine, Université libre de Bruxelles, Erasme Campus, 808 route de Lennik, 1070 Brussels, Belgium., Nortier J; Nephrology Department, Brugmann University Hospital, Université libre de Bruxelles, 4 place Van Gehuchten, 1020 Brussels, Belgium.; Laboratory of Experimental Nephrology, Faculty of Medicine, Université libre de Bruxelles, Erasme Campus, 808 route de Lennik, 1070 Brussels, Belgium.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 19; Vol. 25 (20). Date of Electronic Publication: 2024 Oct 19.

Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis .

Autor: Poivre M; Laboratory of Experimental Nephrology, Faculty of Medecine, Université Libre de Bruxelles, 1000 Bruxelles, Belgium.; Saint-Petersburg Institute of Pharmacy, 197376 Saint Petersburg, Russia.; Laboratory of Therapeutic Chemistry and Pharmacognosy, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons-UMONS, 7000 Mons, Belgium., Antoine MH; Laboratory of Experimental Nephrology, Faculty of Medecine, Université Libre de Bruxelles, 1000 Bruxelles, Belgium., Kryshen K; Saint-Petersburg Institute of Pharmacy, 197376 Saint Petersburg, Russia., Atsapkina A; Saint-Petersburg Institute of Pharmacy, 197376 Saint Petersburg, Russia., Shikov AN; Department of Technology of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, Prof. Popov 14a, 197376 Saint Petersburg, Russia., Twyffels L; CMMI Center for Microscopy and Molecular Imaging, 6041 Charleroi, Belgium., Nachtergael A; Laboratory of Therapeutic Chemistry and Pharmacognosy, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons-UMONS, 7000 Mons, Belgium., Duez P; Laboratory of Therapeutic Chemistry and Pharmacognosy, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons-UMONS, 7000 Mons, Belgium., Nortier J; Laboratory of Experimental Nephrology, Faculty of Medecine, Université Libre de Bruxelles, 1000 Bruxelles, Belgium.

Publikováno v: Toxins [Toxins (Basel)] 2023 Jan 06; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 06.

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Autor: Baudoux T; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium., Jadot I; Molecular Physiology Research Unit (URPhyM), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Namur, Belgium., Declèves AE; Laboratory of Molecular Biology, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons (UMONS), Mons, Belgium., Antoine MH; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium., Colet JM; Department of Human Biology & Toxicology, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons (UMONS), Mons, Belgium., Botton O; Molecular Physiology Research Unit (URPhyM), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Namur, Belgium., De Prez E; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium., Pozdzik A; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium., Husson C; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium., Caron N; Molecular Physiology Research Unit (URPhyM), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Namur, Belgium., Nortier JL; Laboratory of Experimental Nephrology, Faculty of Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 May 04; Vol. 9, pp. 822870. Date of Electronic Publication: 2022 May 04 (Print Publication: 2022).

Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer.

Autor: Chraibi S; Unit of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: selma.chraibi@ulb.be., Rosière R; Unit of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium; InhaTarget Therapeutics, Rue Auguste Piccard 37, 6041 Gosselies, Belgium., De Prez E; Laboratory of Experimental Nephrology, Faculty of Medicine, ULB, Brussels, Belgium., Gérard P; InhaTarget Therapeutics, Rue Auguste Piccard 37, 6041 Gosselies, Belgium., Antoine MH; Laboratory of Experimental Nephrology, Faculty of Medicine, ULB, Brussels, Belgium., Langer I; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), ULB, Brussels, Belgium., Nortier J; Laboratory of Experimental Nephrology, Faculty of Medicine, ULB, Brussels, Belgium., Remmelink M; Department of Pathology, ULB, Hôpital Erasme, Brussels, Belgium., Amighi K; Unit of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium., Wauthoz N; Unit of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jul; Vol. 139, pp. 111716. Date of Electronic Publication: 2021 May 16.